2024년도 기조 연사 : 상세 정보
Shaping the Next Stage of Antibody Development with Complex Modalities and Combinations
복잡한 모달리티와 조합에 의한 다음 단계 항체 개발의 구체화
Christian Klein, PhD
Roche Innovation Center
Immunotherapy Highlights
Taruna Arora, PhD
Bristol Myers Squibb
Multispecific Antibody Highlights
Tomoyuki Igawa, PhD
Chugai Pharmabody Research
ADC Highlights
Hironori Matsunaga, PhD
Daiichi Sankyo
PEGS EUROPE 소개
PEGS Europe은1,500명 이상의 참가자 타사가 참가하는 유럽 최대의 단백질·항체 엔지니어링 컨퍼런스로, '유럽 최고의 생물제제 기술 컨퍼런스'로도 평가되고 있습니다. 올해 컨퍼런스에서는 대상 분야를 인공지능/기계학습(AL/ML) 및 다중특이성항체, 항체·약물 복합체, 또한 종양 관련 전스트림까지 넓히고 있습니다. 2024년 컨퍼런스의 특징은 다음과 같습니다. :
COLLEAGUE TESTIMONIALS
“The best biologics technology meeting in Europe: a must-attend conference for novel biologics.”
Rakesh D., PhD, President & CEO, Bionavigen
“ I was very much impressed by the quality of the event, the depth and breadth of the presentations, as well as the scientific discussions and excitement. This is the event to participate and enjoy.”
Yan Q., PhD, Senior Principal Scientist, Rinat Pfizer
“Excellent event as usual. I always learn a substantial amount of info while at PEGS Europe.”
Christian K., PhD, Distinguished Scientist, Roche Innovation Center Zurich
“I truly enjoyed participating at the PEGS Congress. I have seen the quality and 'quantity' of the congress improving every year.”
Dario N., PhD, Full Professor, Chemistry and Applied Biosciences, ETH Zurich
Friends of PEGS Europe,
